Concepedia

Chris A. Willoughby

CA

3

Publications

123

Citations

3

H-Index

2001

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Chris A. Willoughby is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and biochemistry.

Top concepts

MedicineBiochemistryPharmacologyDrug DiscoveryNatural SciencesMedicinal ChemistryDiabetesMetabolismMetabolomicsSpectroscopy

Publications per year

2001–2003

3

Publications

3

Glucose-lowering in a db/db mouse model by dihydropyridine diacid glycogen phosphorylase inhibitors

Anthony K. Ogawa, Chris A. Willoughby, Raynald Bergeron et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 64 citations · Full text

Energy Metabolism, Db/db Mouse Model, Biochemistry +6

Novel 3,4-Dihydroquinolin-2(1 H )-one inhibitors of human glycogen phosphorylase a

Keith G. Rosauer, Anthony K. Ogawa, Chris A. Willoughby et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 36 citations · Full text

Medicinal Chemistry, Aldehyde Dehydrogenase, Aldo-keto Reductase +10

Mass Spectrometry Screening of Combinatorial Mixtures, Correlation of Measured and Predicted Electrospray Ionization Spectra

Nathan A. Yates, Daniel Wislocki, Andrew D. Roberts et al. · Analytical Chemistry · 2001 · 23 citations

Combinatorial Chemistry, Complex Mixtures, Spectrochemical Analysis +23

Rows per page

1–3 of 3